menu icon
graph icon close icon

News

Press Releases

search field
Months
Years
  
Subscribe for Email Alerts
Jun 05, 2020 / 6:00 AM ET
Press Release

United Therapeutics Corporation Files Lawsuit Against Liquidia For Infringement Of Tyvaso Patents

6/5/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 5, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has filed a lawsuit in the U.S. District Court...

May 26, 2020 / 6:00 AM ET
Press Release

United Therapeutics Corporation to Present at the Jefferies Virtual Health Care Conference

5/26/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 26, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond, Chief Financial Officer and Tr...

May 06, 2020 / 6:00 AM ET
Press Release

United Therapeutics Corporation To Present At The BofA Securities Virtual Health Care Conference 2020

5/6/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 6, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Mr. James Edgemond, Chief Financial Officer and Tre...

Apr 29, 2020 / 6:00 AM ET
Earnings Release

United Therapeutics Corporation Reports First Quarter 2020 Financial Results

4/29/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 29, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the quarter ended March 31,...

Apr 23, 2020 / 6:00 AM ET
Press Release

United Therapeutics Announces Additional Results From FREEDOM-EV Study Showing The Hemodynamic And Risk Status Reduction Benefits Of Orenitram Treatment In Patients With Pulmonary Arterial Hypertension

4/23/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 23, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today detailed recent publications on Orenitram® (treprostinil) Exten...

Apr 22, 2020 / 6:00 AM ET
Press Release

United Therapeutics Corporation to Report First Quarter 2020 Financial Results Before the Market Opens on Wednesday, April 29, 2020

4/22/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 22, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its first quarter 2020 financial...

Feb 26, 2020 / 6:00 AM ET
Earnings Release

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2019 Financial Results

2/26/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 26, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced its financial results for the fourth quarter and year...

Feb 25, 2020 / 6:00 AM ET
Press Release

United Therapeutics Corporation To Present At The 40th Annual Cowen And Company Healthcare Conference

2/25/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that Michael Benkowitz, President and Chief Operating...

Feb 24, 2020 / 6:16 AM ET
Press Release

United Therapeutics and DEKA Announce Additional FDA Clearance Related to the Unity Subcutaneous Delivery System for Remodulin®

2/24/2020

RESEARCH TRIANGLE PARK, N.C. and MANCHESTER, N.H., Feb. 24, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) and DEKA Research & Development Corp. today announced receipt of an...

Feb 24, 2020 / 6:00 AM ET
Press Release

United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints

2/24/2020

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 24, 2020 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that preliminary analysis indicates that the INCREASE...

Displaying 1 to 10 (of 366 releases)